We and others have observed significant vimentin expression within PBMC cell populations [45]; consequently, we used TaqMan assays targeting EpCAM and ARHGAP29 transcripts for specific identification of prostate cancer cells. This evidence concerns the gene VIM and prostate carcinoma.